Pricing

Encysive Pharmaceuticals Inc (ENCY)

followers ·
Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
7000 FANNIN HOUSTON, TX 77030

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

    Formally known as:
  • Texas Biotechnology Corp.
Encysive Pharmaceuticals is a biopharmaceutical company engaged in the discovery, development and commercialization of novel, synthetic, small molecule compounds for the treatment of a variety of cardiovascular, vascular and related inflammatory diseases. Co.'s research and development programs are predominantly focused on the treatment and prevention of interrelated diseases of the intravascular inflammatory process, referred to as the inflammatory cascade, and vascular diseases. Co. has developed one Food and Drug Administration approved drug, Argatroban, for the treatment of heparin-induced thrombocytopenia (HIT) that is marketed by GlaxoSmithKline.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available